Considering that a 3% increase in residual LAL enzyme activity is enough to distinguish Wolman disease, which is lethal in infancy, from the much milder CESD60, a 10% increase in functional LAL would be predicted to have clinical benefit. Here, LIPA is linked to Wolman disease.